Jing Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing Bai has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Fan Wu
Department of Neurology, the First Hospital of Jilin University, Changchun, China
1 shared publicationHuidi Teng
Department of Neurology, the First Hospital of Jilin University, Changchun, China
1 shared publicationTao Tian
Department of Cardiology, The First Hospital of Jilin University, Changchun, China
1 shared publicationXiaohan Li
Department of Neurology, the First Hospital of Jilin University, Changchun, China
1 shared publicationXu Wang
Department of Neurology, the First Hospital of Jilin University, Changchun, China
1 shared publication
Latest Publications
- 11 November 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 268 (12) , 4630-4645
Spinocerebellar ataxia type 23 (SCA23): a review
Spinocerebellar ataxias (SCAs), formerly known as autosomal dominant cerebellar ataxias (ADCAs), are a group of hereditary heterogeneous neurodegenerative diseases. Gait, progressive ataxia, dysarthria, and eye movement disorder are common symptoms of spinocerebellar ataxias. Other symptoms include peripheral neuropathy, cognitive impairment, psychosis, and seizures. Patients may lose their lives due to out of coordinated respiration and/or swallowing. Neurological signs cover pyramidal or extrapyramidal signs, spasm, ophthalmoplegia, hyperactive deep tendon reflexes, and so on. Different subtypes of SCAs present various clinical features. Spinocerebellar ataxia type 23 (SCA23), one subtype of the SCA family, is characterized by mutant prodynorphin (PDYN) gene. Based on literatures, this review details a series of SCA23, to improve a whole understanding of clinicians and point out the potential research direction of this dysfunction, including a history, pathophysiological mechanism, diagnosis and differential diagnosis, epigenetics, penetrance and prevalence, genetic counseling, treatment and prognosis.
- 11 November 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 268 (12) , 4630-4645
Spinocerebellar ataxia type 23 (SCA23): a review
Spinocerebellar ataxias (SCAs), formerly known as autosomal dominant cerebellar ataxias (ADCAs), are a group of hereditary heterogeneous neurodegenerative diseases. Gait, progressive ataxia, dysarthria, and eye movement disorder are common symptoms of spinocerebellar ataxias. Other symptoms include peripheral neuropathy, cognitive impairment, psychosis, and seizures. Patients may lose their lives due to out of coordinated respiration and/or swallowing. Neurological signs cover pyramidal or extrapyramidal signs, spasm, ophthalmoplegia, hyperactive deep tendon reflexes, and so on. Different subtypes of SCAs present various clinical features. Spinocerebellar ataxia type 23 (SCA23), one subtype of the SCA family, is characterized by mutant prodynorphin (PDYN) gene. Based on literatures, this review details a series of SCA23, to improve a whole understanding of clinicians and point out the potential research direction of this dysfunction, including a history, pathophysiological mechanism, diagnosis and differential diagnosis, epigenetics, penetrance and prevalence, genetic counseling, treatment and prognosis.